Dr. Mesa on Ruxolitinib in Chronic Myeloid Leukemia
1 विचारों
• 07/08/23
0
0
एम्बेड
administrator
ग्राहकों
Ruben A. Mesa, MD, Professor of Medicine, Division of Hematology & Medical Oncology, Mayo Clinic, discusses the mechanism of action of ruxolitinib in chronic myeloid leukemia.
More on hematologic malignancies: http://www.onclive.com/special....ty/hematologic-cance
और दिखाओ
फेसबुक टिप्पणियाँ
SORT BY-
सबसे ऊपर की टिप्पणी
-
नवीनतम टिप्पणियां